SPADARO, Aldo
 Distribuzione geografica
Continente #
NA - Nord America 963
EU - Europa 791
AS - Asia 214
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.971
Nazione #
US - Stati Uniti d'America 958
IE - Irlanda 243
SE - Svezia 235
CN - Cina 128
UA - Ucraina 105
DE - Germania 75
SG - Singapore 73
FI - Finlandia 48
GB - Regno Unito 44
BE - Belgio 18
IT - Italia 18
IN - India 10
CA - Canada 5
RU - Federazione Russa 2
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
JO - Giordania 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TR - Turchia 1
Totale 1.971
Città #
Dublin 243
Jacksonville 214
Chandler 176
Nyköping 127
Beijing 82
Ashburn 70
Ann Arbor 67
Singapore 59
Cambridge 38
Princeton 37
Des Moines 31
Medford 30
Lancaster 26
Boardman 23
Dearborn 22
Woodbridge 20
Brussels 18
Los Angeles 18
San Mateo 12
Munich 10
Pune 10
Jinan 9
Espoo 6
Helsinki 5
Mountain View 5
Haikou 4
Changsha 3
Ningbo 3
Norwalk 3
Salerno 3
Taizhou 3
Washington 3
Wilmington 3
Auburn Hills 2
Bolzano 2
Cene 2
Chicago 2
Hangzhou 2
Messina 2
Nanchang 2
Nanjing 2
Ottawa 2
Seattle 2
Shenyang 2
Taiyuan 2
Zhengzhou 2
Amman 1
Ardabil 1
Auckland 1
Boston 1
Bremen 1
Chongqing 1
Fort Payne 1
Fuzhou 1
Ganzhou 1
Granby 1
Guangzhou 1
Hefei 1
Kunming 1
Lanzhou 1
Laval 1
London 1
Milan 1
Montréal 1
Palermo 1
Phoenix 1
Prague 1
Saint Louis 1
Shanghai 1
Stockholm 1
Tianjin 1
Totale 1.434
Nome #
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 92
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 88
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 83
null 81
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 79
Randomised trial of two different daily doses of interferon- alpha versus classical therapy in treatment-naive patients with chronic hepatitis C 71
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 66
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 58
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 58
[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 58
Ten year follow-up of patients with chronic hepatitis C treated with interferon 56
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. 56
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 54
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 53
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 51
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data 50
Does malnutrition affect survival in cirrhosis? 50
Farmaci di più comune uso in gastroenterologia 50
PREVALENCE OF ANTI-HCV ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE AND ITS RELATIONSHIP TO HBV AND HDV INFECTIONS 50
Current practice of hepatitis C treatment in Southern Italy. 50
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 49
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 49
Toxicity of IFN plus ribavirin in patients with chronic hepatitis C. A multicenter retrospective study 48
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C 48
Clinical Outcome of HBeAg-Negative Chronic Hepatitis B in Relation to Virological Response to Lamivudine 48
Cultural representation of newborn feeding 47
NON-ALCOHOLIC FATTY LIVER DISEASE: A MULTICENTRE CLINICAL STUDY BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 46
Terapia dell'epatite cronica C: 10 anni di esperienze 46
Re-treatment with interferon plus ribavirin of chronic hepatitis C nonresponders to interferon monotherapy: A meta- analysis of individual patient data 43
FULMINANT HEPATIC FAILURE AND AUTOIMMUNE DISORDERS IN PATIENT WITH MULTIPLE SCLEROSIS ON INTERFERON BETA 1A: A FATAL COMBINATION? 42
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 42
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 41
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. 41
Randomized trial of two different daily doses of alpha-interferon versus classical treatment in naive patients with chronic hepatitis C 36
Current practice of chronic hepatitis B treatment in Southern Italy. 36
Current practice of hepatitis C treatment in Southern Italy. 32
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. 31
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder 1
Totale 1.980
Categoria #
all - tutte 8.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020222 0 0 0 0 0 24 42 33 4 66 51 2
2020/2021238 35 2 50 15 5 36 2 28 3 30 17 15
2021/2022240 2 30 5 14 14 3 8 7 4 42 41 70
2022/2023698 48 64 51 35 62 66 7 52 284 5 19 5
2023/2024161 7 32 10 21 16 45 8 16 0 1 0 5
2024/2025119 4 21 14 65 8 7 0 0 0 0 0 0
Totale 1.980